Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Helicobacter pylori adhesion system is a complex network of bacterial outer membrane proteins (adhesins) and their corresponding host receptors on the gastric mucosa, essential for the bacterium's ability to colonize and persist in the human stomach [1.1.2, 1.1.3]. Primary adhesins include the Blood group antigen-binding adhesin (BabA), which targets Lewis b antigens, and the Sialic acid-binding adhesin (SabA), which binds to inflammation-associated sialyl-Lewis X antigens [1.1.2, 1.3.2]. Other critical components include HopQ, which interacts with host Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAMs), and CagL, which binds to host integrins to facilitate the delivery of the CagA virulence factor [1.1.1, 1.3.3]. This adhesion process allows H. pylori to resist mechanical clearance by gastric peristalsis and mucus shedding, while also triggering host signaling pathways that lead to chronic inflammation, peptic ulcers, and gastric adenocarcinoma [1.1.3, 1.3.4]. Therapeutic strategies targeting these adhesion sites, such as glycan mimetics like 3'-sialyllactose, anti-adhesin antibodies, and probiotics, aim to prevent colonization and reduce the pathogenic burden [1.2.1, 1.2.3, 1.3.1]. This system represents a promising therapeutic target, particularly for addressing the challenge of rising antibiotic resistance in H. pylori infections [1.2.2, 1.2.5].
Competitive inhibition of bacterial adhesin binding to host glycan receptors, steric hindrance of adhesin-receptor complexes, and modulation of bacterial outer membrane protein expression [1.2.1, 1.2.2].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori adhesion system.